Urinary Catheters Market to Partake Significant Development During 2018 to 2024

The global urinary catheters market is expected to reach USD 5.51 billion by 2024, according to a new report by Grand View Research, Inc. The key contributors for the expansion of the market include the rising incidence of urinary disorders, growing elderly population, and technological advancements pertaining to the relevant devices.

These catheters have application in patients suffering from urinary retention, urinary incontinence, benign prostatic hyperplasia, and other disorders. Patients suffering from multiple sclerosis, spina bifida, cerebral palsy, spinal cord injuries, prostate enlargement, and cancer also require need them The WHO states that bladder problems affect more than 200 million people globally. Benign Prostate Hyperplasia (BPH) is most common in the ageing population, especially men, and urinary retention is a very common complication in BPH. Transurethral resection of the prostate is a common surgery for BPH and the Urology Care Foundation estimates that around 150,000 men in the U.S. undergo this surgery each year.

The technological development pertaining to these instruments are expected to drive the demand further. The catheters become infected after a couple of weeks and can cause infection of the tract. The development of new antimicrobial catheters with introduced antimicrobial molecules within the tube has advantage over the traditional ones.

Furthermore, the reimbursement policies for these products can also be attributed to the growing demand. The Medicaid program reimburses a patient with 120 intermittent catheters per month and the Medicare Program reimburses around 200 catheters per month.

Access Research Report of Urinary Catheters Market@ www.grandviewresearch.com/industry-analysis/urinary-catheters-market

Further Key Findings From the Study Suggest:

• In 2015, intermittent catheters was the dominant segment due to less chances of infections associated with their usage and thus being more preferred over the other two types
• In 2015, urinary incontinence was the largest application segment due to the rising prevalence of the disease with aging population.
• North America dominated the market in 2015. The U.S. is the largest market in North America owing to the high prevalence of urology disorders, rising geriatric population, and reimbursement policies.
• Asia Pacific is expected to be the fastest growing during the forecast period owing to the improving infrastructure in emerging economies and increasing interest of large players in this region
• The market dynamics indicate the presence of strong competition amongst the key players like Coloplast; Boston Scientific Corporation; Hollister, Inc.; B Braun Melsungen AG; Teleflex Inc.; Medtronic and many others.

Grand View Research has segmented the urinary catheters market by product, application, and region:

Urinary Catheters Product Type Outlook (Market revenue in USD Million, 2013 - 2024)

• Intermittent catheters
• Foley/ Indwelling catheters
• External catheters

Urinary Catheters Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Benign prostate hyperplasia and prostate gland surgeries
• Urinary incontinence
• Spinal cord injury
• Others

Urinary Catheters Regional Outlook (Market revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Coagulation Analyzer Market to Grow at CAGR of 10.2% through 2024

The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

• Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
• Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
• Automatic reflex testing, repeat testing, and redilution

Access Research Report of Coagulation Analyzer Market@ www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market

Further key findings from the study suggest:

• Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
• Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
• Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
• Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
• The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
• Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
• For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region.

Product Outlook (Revenue, USD Million, 2013 - 2024)

• Analyzers
  • Clinical Laboratory Analyzers
  • Point of Care Analyzers   
• Consumables
  • Reagents
  • Stains

Technology Outlook (Revenue, USD Million, 2013 - 2024)

• Mechanical
• Electrochemical
• Optical
  • Photo optical/Chromogenic/Immuno
  • Others/Nephelometric
• Others

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• APTT
• D-Dimer
• Fibrinogen
• Prothrombin
• Others

End-Use Outlook (Revenue, USD Million, 2013 - 2024)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Infection Control Market Expected to Witness a Sustainable Growth over 2025|Key participants STERUS Corporation, Cantel Medical Corporation

The global infection control market is expected to reach USD 258.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by rising concerns with respect to a significant upsurge in hospital acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall infection control market.

The healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern. In addition, increasing number intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years.

For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in wide array of healthcare settings such as ambulatory care, home care, hospitals, and others. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights.

Access Research Report of Infection Control Market@ www.grandviewresearch.com/industry-analysis/infection-control-market

Further key findings from the report suggest:

• In the type segment, services are predicted to observe exponential growth as a consequence of increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost efficiency
• In the end-use segment, hospitals accounted for substantial share in 2016, as a consequence of high clinical urgency to curb the growing incidence of hospital acquired infections
• North America captured a dominant share of the overall infection control market owing to extensive infection prevention activities being implemented in hospitals, medical device and pharmaceutical companies
• The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to spread of infections within healthcare settings and measures for prevention
• The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers & acquisitions resulting in significant growth in their market share
• For instance, in July 2016, the Getinge Group acquired 1stCall Mobility Ltd, a company specializing in supplying rental equipment. This acquisition was carried out as a part of the company’s expansion strategy

Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

Infection Control Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Equipment
• Services
• Consumables

Infection Control End-use Outlook (Revenue, USD Billion, 2014 - 2025)

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Infection Control Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Osteoporosis Drugs Market Revenue Sales to Reach USD 16.3 Billion by 2025

The global osteoporosis drugs market is expected to reach USD 16.3 billion by 2025, according to a new study by Grand View Research, Inc. An upsurge rise in the unhealthy lifestyle adoption has resulted in aggravation and increase in the prevalence of osteoporosis which is presumed to propel the osteoporosis drugs market during the forecast period.

In addition, growing number of patent expiries is fueling the high clinical urgency to use generic versions of the established drugs, which is presumed to fuel generic osteoporosis drugs market during the forecast period. The aforementioned factors cumulatively are slated to present the with high potential growth opportunities over the coming years.

Furthermore, rising number of initiatives to increase the awareness levels pertaining to osteoporosis care amongst the patients as well as the physicians is expected to widen the osteoporosis market growth potential during the forecast period. For instance, National Osteoporosis Foundation (NOF), a healthcare organization responsible for National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs that focuses on elevating awareness levels as well as provides training to healthcare professionals

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/osteoporosis-drug-market

Further key findings from the study suggest:

• Branded drugs held the dominant share of the product segment in 2015. The dominant share can be attributed to extensive utilization of bisphosphates, rank ligand inhibitors for the treatment of osteoporosis, possessing high efficacy
• Generics are expected to witness at a lucrative CAGR owing to consistent patent expiries over the coming years as well as high clinical urgency for inexpensive medication in the emerging economies
• In 2015, North America accounted for the largest share in the global osteoporosis drugs market owing to the presence of established companies extensively involved in the commercialization of branded therapeutics
• Asia Pacific is anticipated to grow at an exponential CAGR as a consequence of favorable government initiatives promoting information pertaining to osteoporosis care
• The key participants are employing sustainability strategies promoting the adoption of osteoporosis therapeutics to gain competitive advantage. For instance, Actavis Inc. announced to acquire Warner Chilcott PLC in order to widen their product portfolio

Grand View Research has segmented the osteoporosis drugs market on the basis of product and region:

Global Osteoporosis Product Outlook (Revenue, USD Million, 2014 – 2025)

• Branded
  • Bisphosphonates
  • Parathyroid Hormone Therapy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator(SERM)
  • Rank Ligand Inhibitors
  • Others
• Generics

Osteoporosis Drugs Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

STD Diagnostics Market Significant Profits Estimated to be Generated by 2022

Global STD diagnostics market is expected to reach USD 200.9 billion by 2022 according to a new study by Grand View Research Inc. The rising geriatric population base, increasing global incidence of various STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the STD diagnostics market growth over the forecast period. 

Increasing number of people having multiple partners and low levels of infection awareness levels are the major drivers fueling industrial growth. Increasing demand for rapid and accurate diagnostic tests and presence of favorable government initiatives for STD testing in developing countries such as Brazil, India, and China are further estimated to boost market growth. 

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market

Further key findings from the study suggest:

• Chlamydia testing accounted for over 34% of the market in 2014. Chlamydia testing for sexually active women aged below 25 years is strictly recommended by the U.S Preventive Services Task Force (PSTF). Syphilis testing is estimated to witness lucrative growth over the forecast period. It is anticipated to grow at a CAGR of 10% owing to increasing prevalence of syphilis infection globally.
• On the basis of test location, laboratory testing held the largest market share of over 63% in 2014 owing to the availability of cost effective diagnostic tests used for multiple STIs at a single location such as public health labs. Point of care on the other hand is anticipated to be the fastest growing segment over the forecast period owing to the owing to the introduction of CLIA waived tests
• Laboratory testing devices dominated the market in 2014 with revenue generation of over 67.0 billion. Immunochromatographic assays were most preferred devices for STD diagnosis in laboratory with revenue share of over 26%. Increasing technological advancements are estimated to enhance usage rates of thermal cyclers over the forecast period.
• Portable/bench top or rapid diagnostic kits are estimated to gain demand over the forecast period owing to features such as user-friendliness, increasing awareness pertaining to self testing, and fast results.
• North America held the largest share of the STD diagnostics market with revenue generation of over 32 billion in 2014. Introduction of technologically advanced diagnostics techniques such as immunochromatographic device by Chembio Diagnostics Systems Inc. is the major factor attributing for its largest market share.
• Asia Pacific region is estimated to witness significant growth over the forecast period owing to the presence of high amount of target population, rising awareness levels for STIs, and increasing government initiatives and rise in disposable income expenditure levels. Asia Pacific is expected to show double digit CAGR growth over the forecast period.
• Major companies of the STD diagnostics industry include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure
• Licensing and partnership deal making activities in the molecular diagnostics sector are growing significantly in terms of value. New entrants such as life science research groups, financial investors, clinical laboratories, and medical technology players drive up the values. 

Grand View Research has segmented the global STD diagnostics market on the basis of product and region:

Global STD Diagnostics Type Outlook (Revenue, USD Billion, 2012 - 2022)

• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
• Others

Global STD Diagnostics Location of Testing Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Testing
  • Commercial/Private Labs
  • Public Health Labs
• Point of Care (PoC) testing

Global STD Diagnostics Testing Device Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Devices
  • Thermal Cyclers - PCR
  • Lateral Flow Readers – Immuno chromatographic assays
  • Flow Cytometers
  • Differential Light Scattering machines
  • Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
• Point of Care (PoC) Devices
  • Phone chips (micro fluidics + ICT)
  • Portable/bench top/rapid diagnostic kits

STD Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Sweden
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Varicose Vein Treatment Market Set to Witness an Uptick by 2024|Top Industry Leaders Medtronic plc, Dornier MedTech GmbH

The Report Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Stripping, And Segment Forecasts To 2024

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

Access Research Report of Varicose Vein Treatment Market @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest: 

• In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
• The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
• In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
• In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
• As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.
• The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
• Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.
• AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.
• In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.
• In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease. 

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions: 

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)

• Sclerotherapy
• Endovenous Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Compressors Market Predicted to Cross USD 315.88 Million by 2020

Global Dental Compressors Market is expected to reach USD 315.88 Million by 2020, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of dental disorders is expected to drive market growth during the forecast period. Introduction of new products based on oil free technology such as AirStar 12 and AirStar 40 which are maintenance free and provide ultra-dry and clean air are also expected to serve the dental compressors market as drivers. Furthermore, commercialization of membrane based compressors is expected to boost usage rates. Key advantages associated with these compressors include low installation and operating costs, no moving parts and their ability to function in hazardous atmospheres. Moreover, membrane based dryers not only supply hygienic, dry and oil free air but also minimize infection risks and increase treatment efficiency by reducing maintenance levels.

Desiccant based dental compressors were the leading product segment in 2013 owing to its characteristic of not reacting chemically with moisture. In most of the European countries, desiccant compressors are more reliable as the weather in the region can get as high as 30 degree Celsius or as low as 0 degree Celsius. The fact that these compressors exhibit optimum performance at these temperature ranges is expected to drive market growth. Desiccant based compressors are expected to grow at a CAGR over 3.0% during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/dental-compressors-market

Further key findings from the study suggest:

• The oil free compressors market is expected to grow at a CAGR of over 6.0% from 2014 to 2020. Key factors attributing to its fast growth includes their compact size and design enabling them to run smoothly with limited vibration and their ability to provide moisture oil and bacteria free dental air with very low maintenance cost.
• Dental compressors in handpieces accounted for over half of the market owing to rising prevalence of dental disorders, growing number of trained dental professional, rising patient awareness levels and increasing healthcare expenditure levels are few factors attributing to the growth of the dental care industry and the consequent rise in demand for dental compressors in handpieces.
• North America dominated the overall market in terms of market share in 2013 majorly on account of the presence of favorable reimbursement policies, economic development and increasing prevalence of dental disorders.
• The Asia Pacific dental compressors market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population base, rising patient awareness levels and growing prevalence of target diseases are few factors attributing to its rapid growth.
• Key players operating in dental compressors include Midmark, Dürr Dental, Gnatus, Metasys, Tech West Inc, Kaeser Dental, Air Techniques, Aixin Medical Equipment Co., Ltd, Foshan Core Deep Medical Apparatus Co. Ltd, Best Dent Equipment Co., Limited, Slovadent, Dental EZ Group, Diplomat Dental Solutions and Fedesa.

For the purpose of this study, Grand View Research has segmented the global dental compressors market on the basis of product, technology, application and region:

Global Dental Compressors Product Outlook (Revenue, USD Million, 2012 – 2020)

• Dental lubricated compressors
• Dental oil-free compressors

Global Dental Compressors Technology Outlook (Revenue, USD Million, 2012 – 2020)

• Desiccant based compressors
• Membrane based compressors

Global Dental Compressors Application Outlook (Revenue, USD Million, 2012 – 2020)

• Handpieces
• Scalers
• Chair Valves

Dental compressors Regional Outlook (Revenue, USD Million, 2012 – 2020)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• MEA
  • Israel
  • South Africa
• Latin America
  • Brazil 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Imaging Market Booming Trends and Forecast Assessment for the Period 2019 to 2026

The global surgical imaging market size is projected to reach USD 7.3 billion by 2026 expanding at a CAGR of 5.2%, according to a new report by Grand View Research, Inc. Technological advancements and growing demand for minimally invasive surgeries are the key factors augmenting the market growth. Surgical imaging can be used with different modalities, such as optical mode, ultrasound, radiography, and nuclear medicine. Rising scope of applications of imaging modules in a wide range of surgery procedures is expected to create significant opportunities.

Demand for surgical imaging systems is expected to show a steep growth due to high prevalence of chronic diseases including cancer and lifestyle disorders, and rising geriatric population, and demand for non-invasive and minimally invasive surgical methods. The endoscopy and laparoscopy devices are extensively used in minimally invasive surgeries. Key companies in the global market use different strategies to sustain the competition. For instance, in June 2017, Philips acquired Electrical Geodesics, Inc. to launch a portfolio with integrated neurological imaging, therapy, and mapping guidance.

Access Research Report of Surgical Imaging Market @ https://www.grandviewresearch.com/industry-analysis/surgical-imaging-market

Further key findings from the study suggest:

• The X-ray segment is expected to lead the market on account of increasing prevalence of chronic diseases and demand for surgical imaging procedures for better treatment
• The demand for mobile X-ray devices is expected to grow rapidly owing to rising geriatric population and need for bedside imaging
• Orthopedic and trauma is anticipated to be the largest and fastest-growing application segment over the forecast years
• C-arms is expected to be the fastest-growing device segment in the global surgical imaging market
• North America accounted for the largest share with U.S. capturing the largest share of the regional market in 2017
• Some of the key companies include Siemens Healthcare; Hitachi Ltd.; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic, Inc.; Medtronic, PLC; and Shimadzu Corporation

Grand View Research has segmented the global surgical imaging market on the basis of device, modality, application, and region:

Surgical Imaging Device Outlook (Revenue, USD Million, 2014 - 2026)

• Endoscopy
• Laparoscopy
• Angiography
• C-arms
• Surgical Navigation Systems

Surgical Imaging Modality Outlook (Revenue, USD Million, 2014 - 2026)

• MRI
• X-ray
• Computed Tomography
• Optical
• Nuclear Imaging
• Ultrasound

Surgical Imaging Application Outlook (Revenue, USD Million, 2014 - 2026)

• Neurosurgeries
• Cardiovascular
• Orthopedic and Trauma
• Gynecological
• Ophthalmological
• Thoracic
• Urologic
• Other

Surgical Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Disposables Market Analysis By Leading Players, Types, Growth Factors, Demand, Opportunities

The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure.

In addition, propelling factors of this sector comprise constantly rising hospital visits, surgeries, and the growing need for healthcare assistance owing to the escalating geriatric population prone to developing chronic diseases and injuries. Furthermore, the emergence of this sector is attributed to the increased focus toward the use of single-use disposable products to prevent cross-contamination and infection in healthcare settings.

These products offer a range of advantages to the healthcare institutions such as reducing sterilization and disinfection costs. Thus, most of the healthcare professionals and individual patients are turning toward disposable medical supplies to meet the infection control requirements.

Drug delivery products captured the largest revenue share in 2015. The segment is also expected to foresee the fastest growth rate due to the increasing use of prefilled syringes, needles, and transdermal patches by various hospitals and clinics.

The plastic resin segment accounted for the largest share in 2015 due to their wide availability and application in the healthcare sector. However, nonwoven material is forecasted to grow at the fastest CAGR owing to factors such as their low weight, affordable cost, and easy recycling methods. Nonwoven fabric is the material of choice for a number of applications such as wound care management, incontinence management, and surgeries due to the highly absorbent and liquid repellent nature of this material, among other properties.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-disposables-market

Further Key Findings from the Study Suggest:

• In 2015, the drug delivery product segment captured the largest revenue share. The increasing application of various drug delivery products for sustained-release drug therapies is mainly contributing to the largest share of the segment globally.
• In addition, rising demand for minimally invasive surgeries is spurring the demand for needles and drug delivery devices, which is resulting in the high revenue generation of the segment
• With the introduction of advanced technology and growing demand for accurate diagnostic methods, the diagnostic and laboratory disposables segment is expected to show the second fastest growth during the forecast period
• North America region dominated the overall market by capturing over 35.0% share in 2015. This region is anticipated to remain dominant throughout the forecast period.
• Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, large patient pool, and the presence of a large number of major players in the region
• Growing economies and government-led initiatives are expected to drive the growth of the medical disposables sector in the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 7% during the forecast period.
• Some of the major players in the consolidated market are 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health

Grand View Research has segmented the medical disposables market by product, raw material, end use, and region:

Type Outlook (Market revenue in USD Million, 2014 - 2024)

• Wound Management Products
• Drug Delivery Products
• Diagnostic and Laboratory Disposables
• Dialysis Disposables
• Incontinence Products
• Respiratory Supplies
• Sterilization Supplies
• Nonwoven Disposables
• Others

Raw Material Outlook (Market revenue in USD Million, 2014 - 2024)

• Plastic Resins
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others

End Use Outlook (Market revenue in USD Million, 2014 - 2024)

• Hospitals
• Home Healthcare
• Outpatient/Primary care Facilities
• Others

Regional Outlook (Market Revenue in USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pyrogen Testing Market Poised to Expand at a Robust Pace Over 2025

The global pyrogen testing market is expected to reach a value of USD 1.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels growth of the market during forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases, is another foremost factor supporting the growth of the pyrogen testing market. The prevalence of chronic diseases is very high in developed countries and is growing at high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise leads to occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.  Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

Access Research Report of Pyrogen Testing Market @ https://www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further key findings from the study suggest:

• Consumables was the largest revenue grossing segment of the pyrogen testing market in 2016, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase
• Instruments segment accounted for the remarkable share in the market in 2016 and is also expected to showcase significant growth during forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis
• The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2016, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development
• North America is the leading regional market and accounted for the largest revenue share in 2016 primarily due to the existence of large number of healthcare companies including pharmaceuticals and medical devices in this region
• The Asia Pacific region is anticipated to be the fastest growing market during the study period. The growing prevalence rate of chronic diseases in the Asian countries including India and China, is a major factor contributing to the expansion of market in this region.
• Some major players serving this vertical include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA; GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates of Cape Cod, Inc.; and Pyrostar

Grand View Research has segmented the pyrogen testing market on the basis of product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Million; 2014 - 2025)

• Consumables
• Instruments
• Services

Pyrogen Testing Test Type Outlook (Revenue, USD Million; 2014 - 2025)

• LAL test
• Chromogenic test
• Turbidimetric test
• Gel clot test
• In vitro pyrogen test         
• Rabbit test

Pyrogen Testing End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Pharmaceutical and biotechnology companies
• Medical devices companies
• Others

Pyrogen Testing Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hyperbaric Oxygen Therapy Devices Market to Expand At A CAGR Of 6.5% through 2025|Key participants IHC Hytech B.V.

The Report Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market Analysis By Product (Monoplace, Multiplace, Topical HBOT Devices), By Application (Wound Healing, Infection Treatment, Gas Embolism), And Segment Forecasts, 2018 - 2025

The global hyperbaric oxygen therapy devices market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.

Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.

According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.

Access Research Report of Hyperbaric Oxygen Therapy Devices Market @ www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further Key Findings From the Report Suggest:

• The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
• Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
• Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
• Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.

Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:

HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Monoplace HBOT Devices
• Multiplace HBOT Devices
• Topical HBOT Devices

HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

• Wound Healing
• Decompression Sickness
• Infection Treatment
• Gas Embolism
• Others

HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ePharmacy Market Expected To Expand At A CAGR Of 14.8% From 2018 To 2025

The global ePharmacy market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Access Research Report of ePharmacy Market @ https://www.grandviewresearch.com/industry-analysis/epharmacies-market

Further Key Findings From the Report Suggest:

• North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
• The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
• Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure
• Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

Grand View Research has segmented the ePharmacy market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Soft Tissue Repair Market To Reap Over USD 10.73 Billion In Revenues By End Of 2025

The global soft tissue repair market size is expected to reach USD 10.73 billion by 2025, expanding at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. Growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years.

Soft tissue comprises of muscles, ligaments, tendons, fibrous tissue, skin, synovial membranes, nerves and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop movement of the bones, which if left untreated can lead to chronic pain. Over the long-term, injuries hamper everyday life of the patients as it becomes difficult to work, socialize or even move. Most of the injuries are caused because of sprain, trauma of strain on the muscles. Soft tissue repair surgery comprises of procedures wherein devices like grafts, sutures, anchors and other devices are used to remodel, reshape or fix the damaged parts to restore its functionality. With the growing number of related injuries, the products used in repair surgeries are expected to witness exponential demand over the forecast period.

Factors influencing soft tissue repair market growth are growing number of patients suffering from sports related injuries. Sprains, contusions, strains, tendinitis, and bursitis are some common injuries, that are suffered by athletes. Growing awareness about impact of these injuries on athletes’ performance and awareness regarding available treatment options for soft tissue repair are expected to promote revenue growth of the market. Ageing population is another significant factor promoting revenue growth. Old people are more susceptible to fractures and trauma associated injury and often require joint replacement and reconstruction surgeries. According to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/soft-tissue-repair-market

Further Key Findings From the Report Suggest:

• The global soft tissue repair market size was estimated at USD 5.73 billion in 2016 and is expected to grow at a CAGR of 7.3% from 2017 to 2025
• Fixation products emerged as the largest product type segment in 2016 and is estimated to generate revenue over USD 6.15 billion by 2025
• Orthopedic surgery segment was estimated at USD 1.47 billion in 2016 and is anticipated to witness fastest growth over the forecast period
• The Asia Pacific region is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. This regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including Stryker Corporation; Arthrex, Inc.; C.R.Bard, Inc., Integra LifeScience Corporation, Smith & Nephew plc. and Depuy Synthes

Grand View Research has segmented the global soft tissue repair market on the basis of product, application and region:

Soft Tissue Repair Product Outlook (Revenue, USD Million, 2014 - 2025)

• Fixation Products
  • Suture
  • Suture Anchors
• Tissue Patch/Match
  • Biological
  • Synthetic

Soft Tissue Repair Application Outlook (Revenue, USD Million, 2014 - 2025)

• Orthopedic Surgery
• Breast Reconstruction
• Hernia Repair
• Skin Repair
• Vaginal Sling Repair
• Cardiovascular Surgery
• Dental Reconstruction
• Others

Soft Tissue Repair Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pruritus Therapeutics Market to Record an Exponential CAGR by 2025

Global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period. Introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period. 

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market

Further key findings from the study suggest:

• Calcineurin inhibitor is identified as the most lucrative segment of the market on account of high usage rate of these drugs in combination therapy for the treatment of pruritus in patients suffering from chronic pruritus and growing market penetration rates. Moreover, the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive this market.
• Anti-histamines owing to its growing use as a first line treatment and presence of drugs in pipeline with expected commercialization is also expected to grow at a healthy rate during the forecast period.
• North America led the overall market in terms of revenue in 2013 majorly on account of the presence of high prevalence of diseases associated with pruritus, introduction of new products targeting the unmet medical needs and growing patient awareness levels.
• The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over 5.0% during the forecast period. Presence of high unmet healthcare needs and increasing prevalence of allergic contact dermatitis and urticaria in this region are some factors attributing to its rapid growth rate.
• Some key participants of the pruritus therapeutics market include Sanofi, Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
• Manufacturers adhere to rigorous R&D in an attempt to develop cost effective products and avoid barriers such as product recalls. In addition, this strategy is implemented keeping the unmet needs in consideration. For Instance, Creabilis has a molecule in the pipeline – CT327, which caters to the unmet needs associated with pruritus in patients suffering from psoriasis. 

Grand View Research has segmented the global pruritus therapeutics market on the basis of product, disease type and region:

Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)

• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others

Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)

• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

Global Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)

• North America
  • US.
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • Rest of Asia Pacific
• RoW 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Human Growth Hormone Market to Expand At A CAGR Of 8.2% from 2020 to 2027

The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Access Research Report of Human Growth Hormone Market @ https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market

Further key findings from the study suggest:

• GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
• Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
• North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
• Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies
• The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.

Grand View Research has segmented the global human growth hormone market on the basis of application, distribution channel, and region:

Human Growth Hormone (hGH) Application Outlook (Revenue, USD Million, 2016 - 2027)

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small for Gestational Age
• Other

Human Growth Hormone (hGH) Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy

Human Growth Hormone (hGH) Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.